An umbrella platform for research, translational, and clinical-stage life-sciences organizations operating under GxP.
Most life-sciences companies assemble quality ad hoc as they grow: a shared drive at the research stage, a spreadsheet when GLP arrives, a binder when the first sponsor audit is announced. It works — until the program succeeds. Then the same records that were good enough for ten people become the evidence base for an IND, a BLA, or a partner's due diligence.
The usual answer is re-platforming at every phase — new tool, new migration, new gaps — while the quality team of one or two carries the institutional memory in their heads. That is the risk an inspector finds first.
The umbrella widens at every phase. GLP (21 CFR 58) requires controlled protocols, trained personnel, and traceable study records. GCP (ICH E6) adds sponsor oversight, CRO qualification, and protocol-deviation management. As manufacturing approaches, GMP expectations arrive — and across all of it, Part 11 and EU Annex 11 govern every electronic record and signature.
Kintavo runs the set as one system from the start: the controlled documents, training chains, and audit trails you build at GLP carry forward to GCP and GMP instead of being rebuilt at each gate.
A Series B biotech, eight months from IND, quality team of two. Kintavo goes live in seven weeks: the SOP library migrates with its history, training chains attach to every protocol, and CRO qualification moves out of email. When the sponsor's auditors arrive, the answer to every request is a record — authored, signed, dated — not a reconstruction. The finding count: zero. The quality lead's weekend: intact.
"Employees praised Kintavo's intuitive design, flexibility, simplicity, and the support received from the team."